参考文献/References:
[1] Siegel RL,Miller KD,Fuchs HE,et al.Cancer statistics,2022[J].CA Cancer J Clin,2022,72(1):7-33.
[2] 刘永鹏,张晶晶,任 艳,等.1990—2019年中国胰腺癌疾病负担变化趋势研究[J].现代预防医学,2022,49(17):3079-3085.
[3] Nakagawa T,Masuda A,Toyama H,et al.Smoking status and the incidence of pancreatic cancer concomitant with intraductal papillary mucinous neoplasm[J].Pancreas,2017,46(4):582-588.
[4] 宋亚邛,胡海燕.VEGF、TGF-β1、CA19-9、CA242和DKK1联合检测对早期胰腺癌临床诊断价值研究[J].陕西医学杂志,2020,49(2):237-240.
[5] Khalaf N,El-Serag HB,Abrams HR,et al.Burden of pancreatic cancer:From epidemiology to practice[J].Clin Gastroenterol Hepatol,2021,19(5):876-884.
[6] 吕小斌,罗和生.胰腺癌危险因素及其与糖尿病相关性研究进展[J].胃肠病学和肝病学杂志,2020,29(12):1425-1430.
[7] Caccialanza R,Lobascio F,Brugnatelli S,et al.Nutritional support in pancreatic cancer[J].Cancer,2020,126(8):1810-1811.
[8] Eibl G,Rozengurt E.Obesity and pancreatic cancer:Insight into mechanisms[J].Cancers(Basel),2021,13(20):5067.
[9] Wiese ML,Aghdassi AA,Lerch MM,et al.Excess body weight and pancreatic disease[J].Visc Med,2021,37(4):281-286.
[10] Zhou P,Li B,Liu B,et al.Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors:A systematic review and meta-analysis[J].Clin Chim Acta,2018,477:94-104.
[11] Batty GD,Kivimaki M,Morrison D,et al.Risk factors for pancreatic cancer mortality:Extended follow-up of the original whitehall study[J].Cancer Epidemiol Biomarkers Prev,2009,18(2):673-675.
[12] Berrington-Degonzalez A,Yun JE,Lee SY,et al.Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study[J].Cancer Epidemiol Biomarkers Prev,2008,17(2):359-364.
[13] Takahashi M,Hori M,Ishigamori R,et al.Fatty pancreas:A possible risk factor for pancreatic cancer in animals and humans[J].Cancer Sci,2018,109(10):3013-3023.
[14] Eibl G,Cruz-Monserrate Z,Korc M,et al.Diabetes mellitus and obesity as risk factors for pancreatic cancer[J].J Acad Nutr Diet,2018,118(4):555-567.
[15] 南昇辰,石 乔,陈 辰,等.胰腺癌与糖尿病的关系[J].临床肝胆病杂志,2022,38(12):2882-2886.
[16] Duan X,Wang W,Pan Q,et al.Type 2 diabetes mellitus intersects with pancreatic cancer diagnosis and development[J].Front Oncol,2021,11:730038.
[17] 陈 娟,朱凤婷,冯冬婵,等.清胰化积汤联合介入化疗栓塞治疗晚期胰腺癌临床研究[J].陕西中医,2023,44(2):178-182.
[18] 郭延玲,胡彦辉.清胰化积方联合顺铂治疗胰腺癌疗效及对TGF-β/smads信号通路的影响[J].陕西中医,2018,39(9):1210-1213.
[19] Weaver JS,Revels JW,Elifritz JM,et al.Clinical manifestations and medical imaging of osteogenesis imperfecta:Fetal through adulthood[J].Acta Med Acad,2021,50(2):277-291.
[20] 董晓玲,齐学林,袁军民,等.糖尿病与恶性肿瘤并存的临床研究进展[J].陕西医学杂志,2013,42(12):1675-1697.
[21] Yuan C,Rubinson DA,Qian ZR,et al.Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus[J].J Clin Oncol,2015,33(1):29-35.
[22] Li D,Morris JS,Liu J,et al.Body mass index and risk,age of onset,and survival in patients with pancreatic cancer[J].JAMA,2009,301(24):2553-2562.
[23] Teoule P,Rasbach E,Oweira H,et al.Obesity and pancreatic cancer:A matched-pair survival analysis[J].J Clin Med,2020,9(11):3526.
[24] Hanahan D.Hallmarks of cancer:New dimensions[J].Cancer Discov,2022,12(1):31-46.
[25] Qin C,Yang G,Yang J,et al.Metabolism of pancreatic cancer:Paving the way to better anticancer strategies[J].Mol Cancer,2020,19(1):50.
[26] Mullen PJ,Yu R,Longo J,et al.The interplay between cell signalling and the mevalonate pathway in cancer[J].Nat Rev Cancer,2016,16(11):718-731.
[27] Ying H,Kimmelman AC,Lyssiotis CA,et al.Oncogenic kras maintains pancreatic tumors through regulation of anabolic glucose metabolism[J].Cell,2012,149(3):656-670.
[28] 殷 玲,韩 菲,路国涛,等.高三酰甘油血症和胰腺疾病的相关性[J].医学综述,2020,26(8):1467-1471.
[29] Tan Z,Lei Y,Xu J,et al.The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction[J].Aging,2020,12(23):24228-24241.
[30] Guillaumond F,Bidaut G,Ouaissi M,et al.Cholesterol uptake disruption,in association with chemotherapy,is a promising combined metabolic therapy for pancreatic adenocarcinoma[J].Proc Natl Acad Sci USA,2015,112(8):2473-2478.
相似文献/References:
[1]宋亚邛,胡海燕△.VEGF、TGF-β1、CA19-9、CA242和DKK1联合检测对早期胰腺癌临床诊断价值研究*[J].陕西医学杂志,2020,49(2):237.
SONG Yaqiong,HU Haiyan..Clinical value analysis of combined examination of VEGF,TGF-β1,CA19-9,CA242 and DKK1 in patients with early pancreatic cancer[J].,2020,49(9):237.
[2]王延磊,王政华△.CT引导下125I粒子植入联合吉西他滨、卡培他滨治疗局部进展期胰腺癌临床疗效观察*[J].陕西医学杂志,2020,49(12):1604.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.017]
WANG Yanlei,WANG Zhenghua..Clinical efficacy of CT-guided 125I particle implantation combined with gemcitabine and capecitabine in treatment of locally advanced pancreatic cancer[J].,2020,49(9):1604.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.017]
[3]王 钰,徐 琳,吕雅丽,等.扫描式葡萄糖监测系统在妊娠期糖尿病患者血糖管理中的应用[J].陕西医学杂志,2021,50(8):962.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.015]
WANG Yu,XU Lin,LYU Yali,et al.Application of flash glucose monitoring in blood glucose management of pregnant women with gestational diabetes mellitus[J].,2021,50(9):962.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.015]
[4]牟春燕,康淑红,刘 晶,等.血清淀粉样蛋白A联合空腹血糖检测在手足口病首诊患儿病情及疾病预后评估中的价值[J].陕西医学杂志,2021,50(12):1554.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.022]
MOU Chunyan,KANG Shuhong,LIU Jing,et al.Value of serum amyloid A combined with fasting blood glucose in evaluation of condition and prognosis of firstly-diagnosed children with hand-foot-mouth disease[J].,2021,50(9):1554.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.022]
[5]习 攀,王 蒨,郭俊俊,等.吉西他滨联合热疗对胰腺癌PANC-1细胞凋亡的影响及机制研究[J].陕西医学杂志,2023,52(9):1130.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.004]
XI Pan,WANG Qian,GUO Junjun,et al.Effect and mechanism of gemcitabine combined with hyperthermia on apoptosis of pancreatic cancer PANC-1 cells[J].,2023,52(9):1130.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.004]
[6]依力哈木·买买提,钟 锴,艾合散·卡马力,等.环状RNA circ_0020123靶向调控微小RNA-145影响胰腺癌细胞SW-1990增殖、侵袭与转移实验研究[J].陕西医学杂志,2023,52(9):1140.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.006]
YILIHAMU Maimaiti,ZHONG Kai,AIHESAN Kamali,et al.Circular RNA circ_0020123 affects proliferation,invasion and metastasis of pancreatic cancer cell SW-1990 by targeting microRNA-145[J].,2023,52(9):1140.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.006]
[7]习 攀,王 蒨,郭俊俊,等.吉西他滨联合热疗对胰腺癌ASPC-1细胞增殖、迁移、侵袭和凋亡的影响及机制研究[J].陕西医学杂志,2023,52(12):1759.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.029]
XI Pan,WANG Qian,GUO Junjun,et al.Effects of gemcitabine combined with hyperthermia on proliferation,migration,invasion and apoptosis of pancreatic cancer ASPC-1 cells and its mechanism[J].,2023,52(9):1759.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.029]